Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Human Fibrinogen Concentrate (RiaSTAP) in Decreasing Blood Loss and the Need for Component Blood Therapy in Infants Undergoing Cardiopulmonary Bypass.

NCT02822599 is registered in ClinicalTrials.gov with Nicklaus Children's Hospital f/k/a Miami Children's Hospital as lead sponsor.

NCT NCT02822599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02822599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Human Fibrinogen Concentrate (RiaSTAP) in Decreasing Blood Loss and the Need for Component Blood Therapy in Infants Undergoing Cardiopulmonary Bypass.
Lead sponsor
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2017
Completion date
December 24, 2020
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

afibrinogenemia, bleeding disorders, hypofibrinogenemia